Monthly Archives: May 2011

Ensuring Clinical Trial Data Quality


A key aspect of clinical trial operational success is getting the right data. Dr Michael Silverman, principal at BioStrategics Consulting Ltd., discusses managing clinical assessments and laboratory procedures to ensure the quality of data acquisition. Last week I discussed operational … Continue reading

Posted in Clinical, Clinical studies, clinical trials, Medical | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

11 CONSIDERATIONS IN CHOOSING THE RIGHT CLINICAL TRIAL SITES


Dr Michael Silverman, principal at BioStrategics Consulting Ltd, discusses clinical trial site selection and its impact on operational success. When we consider operational success, there are two distinct aspects: Getting the Right Data and Getting the Data Right. The first … Continue reading

Posted in Clinical, Clinical studies, clinical trials | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

CLINICAL DEVELOPMENT: THE CLINICAL TRIAL SAMPLE SIZE


Dr Michael Silverman, principal at BioStrategics Consulting Ltd, discusses clinical trial sample size as an important aspect of the clinical trial protocol. This week I would like to discuss certain considerations around clinical trial sample size in defining a successful … Continue reading

Posted in Clinical, Clinical studies, clinical trials | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

CLINICAL DEVELOPMENT: CLINICAL TRIAL DESIGN


Dr Michael Silverman, principal at BioStrategics Consulting Ltd, discusses clinical trial design as an important aspect of the Clinical Trial Protocol. This week I would like to discuss the importance of clinical trial design in defining a successful clinical trial … Continue reading

Posted in Clinical, Clinical studies, clinical trials, Medical | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Clinical Development: The Clinical Trial Protocol Patient Population


Dr Michael Silverman, principal at BioStrategics Consulting Ltd, continues his discussion this week on the Clinical Trial Protocol. To achieve a successful protocol, the choice of the patient population is critical. This week I would like to discuss a make … Continue reading

Posted in Clinical, Clinical studies, clinical trials | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment